78% of Indian Consumers Use Generative AI for Diagnoses, Bain Report Says

For healthcare IT leaders, India's 78% consumer adoption rate of generative AI for medical diagnoses signals a watershed moment. As patients increasingly use AI to prepare for appointments and navigate care, the pressure mounts on providers to integrate intelligent, patient-facing tools. The Bain report reveals not just high demand, but also critical gaps in care coordination that digital health solutions can bridge.

The Bain & Company report released on June 17, 2026, positions India as one of the most AI-ready healthcare markets in the Asia-Pacific region. With 78% of Indian consumers using generative AI to understand diagnoses and treatment options, the country leads in consumer-driven adoption. This statistic reflects a broader shift toward digital health, spearheaded by Gen Z, who show higher engagement with AI-enabled tools and online pharmacies (66% usage rate). The report also reveals that 73% of consumers use AI to prepare for medical appointments, and 72% rely on it to navigate the complex healthcare system.

“

Affordability is a major barrier, cited by 43% of respondents, alongside long wait times (42%) and appointment delays (30%).

However, this readiness coexists with significant systemic challenges. Affordability is a major barrier, cited by 43% of respondents, alongside long wait times (42%) and appointment delays (30%). Fragmentation remains a critical issue: 45% of consumers find the healthcare system difficult to navigate, and 62% report needing multiple consultations before receiving a correct diagnosis. These pain points are compounded by rising consumer expectations: 88% want more convenient experiences, 79% expect accessible communication with doctors via phone or messaging, and a striking 93% desire a single point of coordination across their care journey.

The disparity between India's AI readiness and actual care delivery highlights a market ripe for disruption. While telehealth adoption has grown, India still lags behind the APAC average in alternate care models (42% vs. 57% regional average). This gap suggests untapped opportunities for health IT companies, telehealth platforms, and AI-driven diagnostic tools. The strain on clinical workforce across Asia-Pacific, as noted in the report, further accelerates the shift toward AI-enabled support and new care models.

For healthcare stakeholders, India represents a dual opportunity: a consumer base eager to adopt AI tools, but also demanding improved access and integration. The high usage of generative AI for pre-appointment preparation and system navigation indicates that AI could bridge the gap between patient expectations and system inefficiency. However, to realize this potential, solutions must address cost and fragmentation. Companies that can offer affordable, integrated platforms—combining telemedicine, AI triage, and care coordination—are well-positioned to capture market share.

The report underscores a generational transformation: Gen Z's adoption of online pharmacies and AI tools sets a precedent that will likely permeate all age groups. As India's digital infrastructure expands, the healthcare sector could leapfrog traditional models, similar to the mobile revolution in banking. Yet, regulatory frameworks and data privacy concerns will need to keep pace. The 78% AI usage rate also raises questions about the quality and reliability of AI-generated health information, necessitating oversight and education.